MedTrace Logo

Steroid Metabolism in Obese and Non-Obese Pediatric Patients Hospitalized for Status Asthmaticus

NCT04874610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2022-07-01

No results posted yet for this study

Summary

Single center, open-label, non-randomized study to assess the pharmacokinetic profile of methylprednisolone in healthy children 2-20 years of age admitted for asthma exacerbation.

Conditions

  • Pediatric Obesity
  • Asthma in Children

Interventions

DRUG

Methylprednisolone

Administration of methylprednisolone Prescribed per Standard of care

Sponsors & Collaborators

Principal Investigators

  • Caitlin King, MD · Duke University

Eligibility

Min Age
2 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04874610 on ClinicalTrials.gov